Abstract
In the current review, we discuss the role of NF-κB and JAK/STAT signaling pathways and their small molecule regulators in the therapy of inflammatory diseases. Considering potential harmful effects directly assigned to the COX-2 inhibition, novel therapeutically-relevant biological targets such as NF-κB and JAK/STAT signaling pathways have received a growing attention. Here we summarize recent progress in the identification and development of novel, clinically approved or evaluated small molecule regulators of these signaling cascades as promising anti-inflammatory therapeutics. In addition, we illustrate key structural modifications and bioisosteric transformations among these inhibitors to provide a helpful basis for further development of novel small molecule anti-inflammatory agents.
Keywords: NF-κB, JAK/STAT, signalling, inhibitors, anti-inflammatory, therapy, Chronic inflammation, rheumatoid arthritis, ischaemic heart disease, atherosclerosis, cancer, fibrosis, Hayfever, Alzheimer's diseases, MAPKs, STAT, NSAIDs, Valdecoxib, leukemia, inflammatory bowel disease, arthritis, sepsis, asthma, multiple sclerosis, colitis, diabetic neuropathy, AIDS, GPCR, TNFR, NEMO, oxycodone/ibuprofen, Oxycodone, Bortezomib, RS-411, Fumaderm, Gabexate, MK-231, Silibinin, ST-1482, RK-0202, Salazosulfapyridine, Curaxin CBLC-102, NGX-3781, Hydrocodone, NSC-49171, Pseudoephedrine, T-614, Curcumin, MPC-7869, Dimethyl fumarate, Famotidine, Fluasterone, Tepoxalin, E-3330, EGCG, Declopramide, Resveratrol, Tranexamic acid, RTA-402, Orazipone, RTA-401, ALS-357, IMD-0354, SIM-688, ENMD-1198, Parthenolide, Cepharanthine, Taxifolin, SC-514, TPCA-1, BMS-345541, ML120B, HUVECs, RHEC, HMGB1, lung lavage, neutrophil influx, lung edema, SOCS, PIAS, Lestaurtinib, MHCII, HWA-486, CP-690550, MK-0457, TG-101348, LS-104, SKI-606, Atiprimod, ABT-869, mixed lymphocyte reaction, mycophenolate mofetil
Mini-Reviews in Medicinal Chemistry
Title: Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Volume: 11 Issue: 1
Author(s): Y. A. Ivanenkov, K. V. Balakin and Y. Lavrovsky
Affiliation:
Keywords: NF-κB, JAK/STAT, signalling, inhibitors, anti-inflammatory, therapy, Chronic inflammation, rheumatoid arthritis, ischaemic heart disease, atherosclerosis, cancer, fibrosis, Hayfever, Alzheimer's diseases, MAPKs, STAT, NSAIDs, Valdecoxib, leukemia, inflammatory bowel disease, arthritis, sepsis, asthma, multiple sclerosis, colitis, diabetic neuropathy, AIDS, GPCR, TNFR, NEMO, oxycodone/ibuprofen, Oxycodone, Bortezomib, RS-411, Fumaderm, Gabexate, MK-231, Silibinin, ST-1482, RK-0202, Salazosulfapyridine, Curaxin CBLC-102, NGX-3781, Hydrocodone, NSC-49171, Pseudoephedrine, T-614, Curcumin, MPC-7869, Dimethyl fumarate, Famotidine, Fluasterone, Tepoxalin, E-3330, EGCG, Declopramide, Resveratrol, Tranexamic acid, RTA-402, Orazipone, RTA-401, ALS-357, IMD-0354, SIM-688, ENMD-1198, Parthenolide, Cepharanthine, Taxifolin, SC-514, TPCA-1, BMS-345541, ML120B, HUVECs, RHEC, HMGB1, lung lavage, neutrophil influx, lung edema, SOCS, PIAS, Lestaurtinib, MHCII, HWA-486, CP-690550, MK-0457, TG-101348, LS-104, SKI-606, Atiprimod, ABT-869, mixed lymphocyte reaction, mycophenolate mofetil
Abstract: In the current review, we discuss the role of NF-κB and JAK/STAT signaling pathways and their small molecule regulators in the therapy of inflammatory diseases. Considering potential harmful effects directly assigned to the COX-2 inhibition, novel therapeutically-relevant biological targets such as NF-κB and JAK/STAT signaling pathways have received a growing attention. Here we summarize recent progress in the identification and development of novel, clinically approved or evaluated small molecule regulators of these signaling cascades as promising anti-inflammatory therapeutics. In addition, we illustrate key structural modifications and bioisosteric transformations among these inhibitors to provide a helpful basis for further development of novel small molecule anti-inflammatory agents.
Export Options
About this article
Cite this article as:
A. Ivanenkov Y., V. Balakin K. and Lavrovsky Y., Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics, Mini-Reviews in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/138955711793564079
DOI https://dx.doi.org/10.2174/138955711793564079 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
Current Pharmaceutical Design microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Plasticity of Neuroendocrine-Immune Interactions During Ontogeny: Role of Perinatal Programming in Pathogenesis of Inflammation and Stress- Related Diseases in Adults
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Serum Interleukin-33 is a Predictor of Depression in Patients with Acute Ischemic Stroke
Current Neurovascular Research Management of Obesity in Pregnancy
Current Women`s Health Reviews Synthesis of New A-CD Estrogenic Compounds: D-Homo-analogs Lacking B-ring
Current Organic Chemistry Clinical Assessment of Central Blood Pressure
Current Hypertension Reviews Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Current Vascular Pharmacology Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
Current Pharmaceutical Design Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Perceval Sutureless Valve – are Sutureless Valves Here?
Current Cardiology Reviews The Control of Arterial Hypertension: Epidemiological and Economic Challenge
Current Hypertension Reviews Statins: A Valuable Tool for the Prevention/Regression of Abdominal Aortic Aneurysms
Vascular Disease Prevention (Discontinued) Trials Comparing Percutaneous And Surgical Myocardial Revascularization: A Review
Reviews on Recent Clinical Trials Cystatin C, Adipokines and Cardiovascular Risk in HIV Infected Patients
Current HIV Research Does the Immune System Regulate Mood to Defend against Infection? Evidence from Studies of Immune Factors, Depression, and Antidepressants
Current Psychiatry Reviews Editorial (Thematic Issue: Angiogenesis in the Development of Cardiovascular Diseases)
Current Angiogenesis (Discontinued) The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets